New FDA-cleared tool aims to speed autism diagnosis, but families ask: What comes next?
The FDA has cleared Neurora, a biometric analysis tool that uses video and audio from standard assessments to help diagnose autism in children ages 18 months to 12 years.
Research shows the tool correctly identifies autism in approximately 78% of cases, with higher accuracy when distinguishing autistic from neurotypical children.
Autism now affects 1 in 31 U.S. children, with median diagnosis age near 4 years—delaying potential intervention.
Earlier eye-tracking technology, EarliPoint, showed 78% sensitivity and 85% specificity in children ages 16-30 months.
Critics and advocates emphasize that diagnostic tools, while valuable, should not overshadow foundational health priorities like nutrition, sleep and reducing environmental toxin exposures.
Read Full Article: https://www.naturalnews.com/2026-10-21-new-fda-cleared-tool-speed-autism-diagnosis.html
